Prognostic impact of dimensional factors in pT1 gastric cancer.


Journal

Surgical oncology
ISSN: 1879-3320
Titre abrégé: Surg Oncol
Pays: Netherlands
ID NLM: 9208188

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 03 12 2020
revised: 10 04 2021
accepted: 11 04 2021
pubmed: 8 5 2021
medline: 18 1 2022
entrez: 7 5 2021
Statut: ppublish

Résumé

The significance of the dimensional factors (tumor diameter, area and volume) as the prognostic factor has not been precisely evaluated in pT1 gastric cancer. This study aimed to identify the clinical impact and to confirm the clinical feasibility of the dimensional factors as prognostic factors in pT1 gastric cancer. We analyzed prognostic factors for disease-specific survival (DSS), overall survival (OS) using clinicopathological factors by univariate and multivariate analyses and the pattern of recurrence in 2011 pT1 gastric cancer (mucosal and submucosal cancers) undergoing R0 gastrectomy. The cut-off values of each dimensional factor was decided by the ROC curve. Cox proportional hazard regression model showed that older age (≥75) and more advanced pN stage were adverse independent prognostic factors for DSS, and revealed that older age (≥75), greater preoperative co-morbid diseases, proximal and total gastrectomy, operative method and Clavien-Dindo classification (≥grade III) were independent adverse factors for OS. Any dimensional factors were not independent prognostic factors for any survival. The dimensional factors do not influence both OS and DSS in pT1 gastric cancer patients and so it is difficult to apply these dimensional factors for conducting therapeutic strategies.

Sections du résumé

BACKGROUND BACKGROUND
The significance of the dimensional factors (tumor diameter, area and volume) as the prognostic factor has not been precisely evaluated in pT1 gastric cancer.
OBJECTIVES OBJECTIVE
This study aimed to identify the clinical impact and to confirm the clinical feasibility of the dimensional factors as prognostic factors in pT1 gastric cancer.
METHODS METHODS
We analyzed prognostic factors for disease-specific survival (DSS), overall survival (OS) using clinicopathological factors by univariate and multivariate analyses and the pattern of recurrence in 2011 pT1 gastric cancer (mucosal and submucosal cancers) undergoing R0 gastrectomy. The cut-off values of each dimensional factor was decided by the ROC curve.
RESULTS RESULTS
Cox proportional hazard regression model showed that older age (≥75) and more advanced pN stage were adverse independent prognostic factors for DSS, and revealed that older age (≥75), greater preoperative co-morbid diseases, proximal and total gastrectomy, operative method and Clavien-Dindo classification (≥grade III) were independent adverse factors for OS. Any dimensional factors were not independent prognostic factors for any survival.
CONCLUSIONS CONCLUSIONS
The dimensional factors do not influence both OS and DSS in pT1 gastric cancer patients and so it is difficult to apply these dimensional factors for conducting therapeutic strategies.

Identifiants

pubmed: 33962215
pii: S0960-7404(21)00073-6
doi: 10.1016/j.suronc.2021.101584
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101584

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Chikara Kunisaki (C)

Department of Surgery, Gastroenterological Center, Medical Center, Yokohama City University, Japan. Electronic address: s0714@med.yokohama-cu.ac.jp.

Masazumi Takahashi (M)

Department of Surgery, Yokohama Municipal Hospital, Japan.

Sho Sato (S)

Department of Surgery, Gastroenterological Center, Medical Center, Yokohama City University, Japan.

Nobuhiro Tsuchiya (N)

Department of Surgery, Gastroenterological Center, Medical Center, Yokohama City University, Japan.

Jun Watanabe (J)

Department of Surgery, Gastroenterological Center, Medical Center, Yokohama City University, Japan.

Tsutomu Sato (T)

Department of Surgery, Gastroenterological Center, Medical Center, Yokohama City University, Japan.

Kazuhisa Takeda (K)

Department of Surgery, Gastroenterological Center, Medical Center, Yokohama City University, Japan.

Yusaku Tanaka (Y)

Department of Gastroenterological Surgery, Yokohama City University, School of Medicine. Japan.

Kohei Kasahara (K)

Department of Gastroenterological Surgery, Yokohama City University, School of Medicine. Japan.

Takashi Kosaka (T)

Department of Gastroenterological Surgery, Yokohama City University, School of Medicine. Japan.

Hirotoshi Akiyama (H)

Department of Gastroenterological Surgery, Yokohama City University, School of Medicine. Japan.

Itaru Endo (I)

Department of Gastroenterological Surgery, Yokohama City University, School of Medicine. Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH